|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The Sahlgrenska Academy at Gothenburg University
2 Karolinska Institutet
3 Lund University
4 Sahlgrenska Hospital
5 Sahlarenska Hospital
* To whom correspondence should be addressed. E-mail: claes.ohlsson{at}medic.gu.se.
In vitro studies suggest that the membrane G protein-coupled receptor GPR30 is a functional estrogen receptor (ER). The aim of the present study was to determine the possible in vivo role of GPR30 as a functional ER primarily for the regulation of skeletal parameters, including bone mass and longitudinal bone growth, but also for some other well-known estrogen-regulated parameters, including uterine weight, thymus weight and fat mass. Three-month-old ovariectomized (ovx) GPR30-deficient mice (GPR30-/-) and wild type (WT) mice were treated with either vehicle or increasing doses of estradiol (E2; 0, 30, 70, 160 or 830 ng/mouse/day). Body composition (bone mineral density (BMD), fat mass and lean mass) was analysed by dual-energy-X ray absorptiometry while the cortical and trabecular bone compartments were analysed by peripheral quantitative computerized tomography. Quantitative histological analyses were performed in the distal femur growth plate. Bone marrow cellularity and distribution were analysed using fluorescence activated cell sorter. The estrogenic responses on most of the investigated parameters, including increase in bone mass (total body BMD, spine BMD, trabecular BMD, cortical bone thickness), increase in uterine weight, thymic atrophy, fat mass reduction and increase in bone marrow cellularity, were similar for all of the investigated E2 doses in WT and GPR30-/- mice. On the other hand, E2 treatment reduced longitudinal bone growth, reflected by decreased femur length and distal femur growth plate height, in the WT mice but not in the GPR30-/- mice compared with vehicle-treated mice. These in vivo findings demonstrate that GPR30 is not required for normal estrogenic responses on several major well-known estrogen-regulated parameters. In contrast, GPR30 is required for a normal estrogenic response in the growth plate.
This article has been cited by other articles:
![]() |
C. Ohlsson and L. Vandenput The role of estrogens for male bone health Eur. J. Endocrinol., June 1, 2009; 160(6): 883 - 889. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |